Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS - PubMed
- ️Invalid Date
doi: 10.1016/j.jcmg.2011.11.012.
Yukio Ozaki, Tevfik F Ismail, Masanori Okumura, Hiroyuki Naruse, Shino Kan, Makoto Ishikawa, Tomoko Kawai, Masaya Ohta, Hideki Kawai, Tousei Hashimoto, Yasushi Takagi, Junichi Ishii, Patrick W Serruys, Jagat Narula
Affiliations
- PMID: 22340823
- DOI: 10.1016/j.jcmg.2011.11.012
Free article
Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS
Kousuke Hattori et al. JACC Cardiovasc Imaging. 2012 Feb.
Free article
Abstract
Objectives: The purpose of this study was to evaluate the effect of statin treatment on coronary plaque composition and morphology by optical coherence tomography (OCT), grayscale and integrated backscatter (IB) intravascular ultrasound (IVUS) imaging.
Background: Although previous studies have demonstrated that statins substantially improve cardiac mortality, their precise effect on the lipid content and fibrous cap thickness of atherosclerotic coronary lesions is less clear. While IVUS lacks the spatial resolution to accurately assess fibrous cap thickness, OCT lacks the penetration of IVUS. We used a combination of OCT, grayscale and IB-IVUS to comprehensively assess the impact of pitavastatin on plaque characteristics.
Methods: Prospective serial OCT, grayscale and IB-IVUS of nontarget lesions was performed in 42 stable angina patients undergoing elective coronary intervention. Of these, 26 received 4 mg pitavastatin after the baseline study; 16 subjects who refused statin treatment were followed with dietary modification alone. Follow-up imaging was performed after a median interval of 9 months.
Results: Grayscale IVUS revealed that in the statin-treated patients, percent plaque volume index was significantly reduced over time (48.5 ± 10.4%, 42.0 ± 11.1%; p = 0.033), whereas no change was observed in the diet-only patients (48.7 ± 10.4%, 50.4 ± 11.8%; p = NS). IB-IVUS identified significant reductions in the percentage lipid volume index over time (34.9 ± 12.2%, 28.2 ± 7.5%; p = 0.020); no change was observed in the diet-treated group (31.0 ± 10.7%, 33.8 ± 12.4%; p = NS). While OCT demonstrated a significant increase in fibrous cap thickness (140 ± 42 μm, 189 ± 46 μm; p = 0.001), such changes were not observed in the diet-only group (140 ± 35 μm, 142 ± 36 μm; p = NS). Differences in the changes in the percentage lipid volume index (-6.8 ± 8.0% vs. 2.8 ± 9.9%, p = 0.031) and fibrous cap thickness (52 ± 32 μm vs. 2 ± 22 μm, p < 0.001) over time between the pitavastatin and diet groups were highly significant.
Conclusions: Statin treatment induces favorable plaque morphologic changes with an increase in fibrous cap thickness, and decreases in both percentage plaque and lipid volume indexes.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Resolution of inflammation, statins, and plaque regression.
Moreno PR, Kini A. Moreno PR, et al. JACC Cardiovasc Imaging. 2012 Feb;5(2):178-81. doi: 10.1016/j.jcmg.2012.01.002. JACC Cardiovasc Imaging. 2012. PMID: 22340824 No abstract available.
Similar articles
-
Watanabe T, Miyamoto T, Miyasita T, Shishido T, Arimoto T, Takahashi H, Nishiyama S, Hirono O, Matsui M, Sugawara S, Ikeno E, Miyawaki H, Akira F, Kubota I. Watanabe T, et al. J Cardiol. 2014 Sep;64(3):236-9. doi: 10.1016/j.jjcc.2013.12.008. Epub 2014 Feb 3. J Cardiol. 2014. PMID: 24503140 Clinical Trial.
-
Plaque characteristics of thin-cap fibroatheroma evaluated by OCT and IVUS.
Miyamoto Y, Okura H, Kume T, Kawamoto T, Neishi Y, Hayashida A, Yamada R, Imai K, Saito K, Yoshida K. Miyamoto Y, et al. JACC Cardiovasc Imaging. 2011 Jun;4(6):638-46. doi: 10.1016/j.jcmg.2011.03.014. JACC Cardiovasc Imaging. 2011. PMID: 21679899
-
Yoshikawa D, Ishii H, Kurebayashi N, Sato B, Hayakawa S, Ando H, Hayashi M, Isobe S, Okumura T, Hirashiki A, Takeshita K, Amano T, Uetani T, Yamada S, Murohara T. Yoshikawa D, et al. Int J Cardiol. 2013 Jan 10;162(2):123-8. doi: 10.1016/j.ijcard.2011.05.047. Epub 2011 Jun 1. Int J Cardiol. 2013. PMID: 21636151
-
Fan H, Zhou J, Yuan Z. Fan H, et al. Am J Cardiol. 2021 Jul 15;151:15-24. doi: 10.1016/j.amjcard.2021.04.013. Epub 2021 May 26. Am J Cardiol. 2021. PMID: 34049675 Review.
-
Zheng G, Chen J, Lin C, Huang X, Lin J. Zheng G, et al. J Interv Cardiol. 2015 Dec;28(6):514-22. doi: 10.1111/joic.12245. Epub 2015 Oct 21. J Interv Cardiol. 2015. PMID: 26487187 Review.
Cited by
-
Wang Z, Cho YS, Soeda T, Minami Y, Xing L, Jia H, Aguirre A, Vergallo R, Lee H, Fujimoto JG, Yu B, Jang IK. Wang Z, et al. Coron Artery Dis. 2016 Aug;27(5):350-6. doi: 10.1097/MCA.0000000000000370. Coron Artery Dis. 2016. PMID: 27105047 Free PMC article. Clinical Trial.
-
Zhang B, Zhang Y, Zhang K, Hu K, Shi Z, Ma L. Zhang B, et al. Heliyon. 2024 Jul 26;10(15):e35240. doi: 10.1016/j.heliyon.2024.e35240. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39161812 Free PMC article.
-
Daida H, Dohi T, Fukushima Y, Ohmura H, Miyauchi K. Daida H, et al. J Atheroscler Thromb. 2019 Jul 1;26(7):592-600. doi: 10.5551/jat.48603. Epub 2019 May 21. J Atheroscler Thromb. 2019. PMID: 31118346 Free PMC article. Review.
-
Cardiovascular Prevention: Migrating From a Binary to a Ternary Classification.
Doneen AL, Bale BF, Vigerust DJ, Leimgruber PP. Doneen AL, et al. Front Cardiovasc Med. 2020 May 22;7:92. doi: 10.3389/fcvm.2020.00092. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 32528979 Free PMC article.
-
Gao WQ, Feng QZ, Li YF, Li YX, Huang Y, Chen YM, Yang B, Lu CY. Gao WQ, et al. BMC Cardiovasc Disord. 2014 May 2;14:60. doi: 10.1186/1471-2261-14-60. BMC Cardiovasc Disord. 2014. PMID: 24886532 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous